Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Minkes

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|July 9, 1976
Thromboxanes: selective biosynthesis and distinct biological propertiesP Needleman, M Minkes, A Raz
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1977
Application of imidazole as a selective inhibitor thromboxane synthetase in human plateletsP Needleman, A Raz, J A Ferrendelli, et al.
Prostaglandins|November 1, 1977
Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensionsP Needleman, B Bryan, A Wyche, et al.
The Journal of Clinical Investigation|March 1, 1977
Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensionsM Minkes, N Stanford, M M Chi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|July 9, 1976
Thromboxanes: selective biosynthesis and distinct biological propertiesP Needleman, M Minkes, A Raz
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1977
Application of imidazole as a selective inhibitor thromboxane synthetase in human plateletsP Needleman, A Raz, J A Ferrendelli, et al.
Prostaglandins|November 1, 1977
Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensionsP Needleman, B Bryan, A Wyche, et al.
The Journal of Clinical Investigation|March 1, 1977
Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensionsM Minkes, N Stanford, M M Chi, et al.
Pageof 1